NMR-derived model of interconverting conformations of an ICAM-1 inhibitory cyclic nonapeptide

Journal of Peptide Research

Volumn 62, Issue 3, 2003, Pages 97-116

  Sillerud, L O ^a   Burks, E J ^a   Wester, M J ^a   Brown, D C ^a   Vijayan, S ^b   Larson, Richard S ^a,c  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Cyclic nonapeptide; Disulfide linked; Inhibitor; Intracellular adhesion molecule 1; Leukocyte functional antigen 1; Nuclear magnetic resonance

Indexed keywords

ALANINE; INHIBITORY PEPTIDE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 INHIBITORY CYCLIC NONAPEPTIDE; LEUKOCYTE FUNCTIONAL ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NONAPEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BETA SHEET; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISULFIDE BOND; GEOMETRY; HUMAN; HUMAN CELL; IC 50; MOLECULAR DYNAMICS; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; TWO DIMENSIONAL NUCLEAR MAGNETIC RESONANCE;

CARRIER PROTEINS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PEPTIDES, CYCLIC; PROTEIN CONFORMATION;

EID: 0041662122     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2003.00070.x     Document Type: Article

References (80)

1. Winter, S.S., Sweatman, J.J., Lawrence, M.B., Rhoades, T.H., Hart, A.L. & Larson, R.S. (2001) Enhanced T-lineage acute lymphoblastic leukaemia cell survival on bone marrow stroma requires involvement of LFA-1 and ICAM-1. Br. J. Haematol. 115, 862-871.
2. Umansky, V., Schirrmacher, V. & Rocha, M. (1996) New insights into tumor-host interactions in lymphoma metastasis. J. Mol. Med. 74, 353-363.
3. Zahalka, M.A., Okon, E. & Naor, D. (1993) Blocking lymphoma invasiveness with a monoclonal antibody directed against the beta-chain of the leukocyte adhesion molecule (CD18). J. Immunol. 150, 4466-4477.
4. Verrier, E.D. & Shen, I. (1993) Potential role of neutrophil anti-adhesion therapy in myocardial stunning, myocardial infarction, and organ dysfunction after cardiopulmonary bypass. J. Card Surg. 8, 309-312.
5. Zhao, Z.Q., Lefer, D.J., Sato, H., Hart, K.K., Jefforda, P.R. & Vinten-Johansen, J. (1997) Monoclonal antibody to ICAM-1 preserves postischemic blood flow and reduces infarct size after ischemia-reperfusion in rabbit. J. Leukoc. Biol. 62, 292-300.
6. Tanaka, Y., Kobayashi, K., Takahashi, A., Arai, I., Higuchi, S., Otomo, S., Habu, S. & Nishimura, T. (1993) Inhibition of inflammatory liver injury by a monoclonal antibody against lymphocyte function-associated antigen-1. J. Immunol. 151, 5088-5095.
7. Clark, W.M., Madden, K.P., Rothlein, R. & Zivin, J.A. (1991) Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 22, 877-883.
8. Kawai, K., Kobayashi, Y., Shiratori, M., Sobue, G., Tamatani, T., Miyasaka, M. & Yoshikai, Y. (1996) Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats. Cell Immunol. 171, 262-268.
9. Kimura, T., Suzuki, K., Inada, S., Hayashi, A., Isobe, M., Matsuzaki, Y., Tanaka, N., Osuga, T. & Fujiwara, M. (1996) Monoclonal antibody against lymphocyte function-associated antigen 1 inhibits the formation of primary biliary cirrhosis-like lesions induced by murine graft-versus-host reaction. Hepatology 24, 888-894.
10. Nishikawa, K., Guo, Y.J., Miyasaka, M., Tamatani, T., Collins, A.B., Sy, M.S., McCluskey, R.T. & Andres, G. (1993) Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis. J. Exp. Med. 177, 667-677.
11. Cosimi, A.B., Conti, D., Delmonico, F.L., Preffer, F.I., Wee, S.L., Rothlein, R., Faanes, R. & Colvin, R.B. (1990) In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J. Immunol. 144, 4604-4612.
12. Katz, S.M., Browne, B., Phan, T., Wang, M.E., Bennett, C.F., Stepkowski, S.M. & Kahan, B.D. (1995) Efficacy of ICAM-1 antisense oligonucleotide in pancreatic islet transplantation. Transplant. Proc. 27, 3214.
13. Degawa, H., Watanabe, K., Uchida, H., Nagao, T., Tomikawa, S., Beck, Y., Nomura, Y., Ichikawa, N., Ando, Y., Kikuchi, K. & Ito, S. (1996) Blocking of ICAM-1 and LFA-1 in rat liver transplantation. Transplant. Proc. 28, 1362-1363.
14. Isobe, M., Yagita, H., Okumura, K. & Ihara, A. (1992) Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255, 1125-1127.
15. Kato, Y., Yamataka, A., Yagita, H., Okumura, K, Fujiwara, T. & Miyano, T. (1996) Specific acceptance of fetal bowel allograft in mice after combined treatment with anti-intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 antibodies. Ann. Surg. 223, 94-100.
16. Nakakura, E.K., Shorthouse, R.A., Zheng, B., McCabe, S.M., Jardieu, P.M. & Morris, R.E. (1996) Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy. Transplantation 62, 547-552.
17. Nakao, Y., Mackinnon, S.E., Strasberg, S.R., Hertl, M.C., Isobe, M., Susskind, B.M., Mohanakumar, T. & Hunter, D.A. (1995) Immunosuppressive effect of monoclonal antibodies to ICAM-1 and LFA-1 on peripheral nerve allograft in mice. Microsurgery. Microsurgery 16, 612-620.
18. Takazawa, K., Hosoda, Y., Bashuda, H., Seino, K., Yagita, H., Tamatani, T., Miyasaka, M. & Okumura, K. (1996) Synergistic effects of mycophenolate mofetil (MMF, RS-61443) and anti-LFA-1/ICAM-1 monoclonal antibodies on the prolongation of heart allograft survival in rats. Transplant. Proc. 28, 1980-1981.
19. Takei, Y., Nishimura, Y., Kawano, S., Nagai, H., Ohmae, A., Fusamoto, H. & Kamada, T. (1996) Expression of ICAM-1 is involved in the mechanism of liver injury during liver transplantation: therapeutic usefulness of the F(ab') 2 fragment of an anti-ICAM-1 monoclonal antibody. Transplant. Proc. 28, 1103-1105.
20. Wegner, C.D., Gundel, R.H., Reilly, P., Haynes, N., Letts, L.G. & Rothlein, R. (1990) Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247, 456-459.
21. Watanabe, S., Mukaida, N., Ikeda, N., Akiyama, M., Harada, A., Nakanishi, I., Nariuchi, H., Watanabe, Y. & Matsushima, K. (1995) Prevention of endotoxin shock by an antibody against leukocyte integrin beta 2 through inhibiting production and action of TNF. Int. Immunol. 7, 1037-1046.
22. Miyamoto, K., Khosrof, S., Bursell, S.E., Rohan, R., Murata, T., Clermont, A.C., Aiello, L.P., Ogura, Y. & Adamis, A.P. (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. USA 96, 10836-10841.
23. Kavanaugh, A.F., Davis, L.S., Jain, R.I., Nichols, L.A., Norris, S.H. & Lipsky, P.E. (1996) A phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis. J. Rheumatol 23, 1338-1344.
24. Davis, L.S., Kavanaugh, A.F., Nichols, L.A. & Lipsky, P.E. (1995) Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis. J. Immunol. 154, 3525-3537.
25. Haug, C.E., Colvin, R.B., Delmonico, F.L., Auchincloss, H. Jr, Tolkoff-Rubin, N., Preffer, F.I., Rothlein, R., Norris, S., Scharschmidt, L. & Cosimi, A.B. (1993) A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55, 766-772.
26. Kavanaugh, A.F., Davis, L.S., Nichols, L.A., Norris, S.H., Rothlein, R., Scharschmidt, L.A. & Lipsky, P.E. (1994). Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule1. Arthritis Rheum. 37, 992-999.
27. Kavanaugh, A.F., Schulze-Koops, H., Davis, L.S. & Lipsky, P.E. (1997) Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody. Arthritis Rheum. 40, 849-853.
28. Vuorte, J., Lindsberg, P.J., Kaste, M., Meri, S., Jansson, S.-E., Rothlein, R. & Repo, H. (1999) Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J. Immunol. 162, 2353-2357.
29. Shannon, J.P., Silva, M.V., Brown, D.C. & Larson, R.S. (2001)) Novel cyclic peptide inhibits intercellular adhesion molecule-1-mediated cell aggregation. J. Pept. Res. 58, 140-150.
30. Nakanishi, H., Ramurthy, S., Raktabutr, A., Shen, R. & Kahn, M. (1993) Peptidomimetics of the immunoglobulin supergene family - a review. Gene 137, 51-56.
31. Murali, R. & Greene, M.I. (1998) Structure-based design of immunologically active therapeutic peptides. Immunol. Res. 17, 163-169.
32. Koivunen, E., Ranta, T.M., Annila, A., Taube, S., Uppala, A., Jokinen, M., van willigen, G., Ihanus, E. & Gahmberg, C.G. (2001) Inhibition of beta(21 integrin-mediated leukocyte cell adhesion by leucine-leucine-glycine motif-containing peptides. J. Cell Biol. 153, 905-916.
33. Krause, K., Pineda, L.F., Peteranderl, R. & Reissmann, S. (2000) Conformational properties of a cyclic peptide bradykinin B2 receptor antagonist using experimental and theoretical methods. J. Pept. Res. 55, 63-71.
34. Viles, J.H., Mitchell, J.B., Gough, S.L., Doyle, P.M., Harris, C.J., Sadler, P.J. & Thornton, J.M. (1996) Multiple solution conformations of the integrin-binding cyclic pentapeptide cyclo(-Ser-D-Leu-Asp-Val-Pro-). Analysis of the (phi, psi) space available to cyclic pentapeptides. Eur. J. Biochem. 242, 352-362.
35. Lowman, H.B., Chen, Y.M., Skelton, N.J., Mortensen, D.L., Tomlinson, E.E., Sadick, M.D., Robinson, I.C. & Clark, R.G. (1998) Molecular mimics of insulin-like growth factor 1 (IGF-1) for inhibiting IGF-1: IGF-binding protein interactions. Biochemistry 37, 8870-8878.
36. Scherf, T., Kasher, R., Balass, M., Fridkin, M., Fuchs, S. & Katchalski-Katzir, E. (2001) A beta -hairpin structure in a 13-mer peptide that binds alpha -bungarotoxin with high affinity and neutralizes its toxicity. Proc. Natl. Acad. Sci. USA 98, 6629-6634.
37. Skelton, N.J., Chen, Y.M., Dubree, N., Quan, C., Jackson, D.Y., Cochran, A., Zobel, K., Deshayes, K., Baca, M., Pisabarro, M.T. & Lowman, H.B, (2001) Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1. Biochemistry 40, 8487-8498.
38. Sem, D.S., Baker, B.L., Victoria, E.J., Jones, D.S., Marquis, D., Yu, L., Parks, J. & Coutts, S.M. (1998) Structural characterization and optimization of antibody-selected phage library mimotopes of an antigen associated with autoimmune recurrent thrombosis. Biochemistry 37, 16069-16081.
39. Lin, K.C. & Castro, A.C. (1998) Very late antigen 4 (VLA4) antagonists as anti-inflammatory agents. Curr. Opin. Chem. Biol. 2, 453-457.
40. Souers, A.J, Virgilio, A.A., Schurer, S.S., Ellman, J.A., Kogan, T.P., West, H.E., Ankener, W. & Vanderslice, P. (1998) Novel inhibitors of alpha 4 beta 1 integrin receptor interactions through library synthesis and screening. Bioorg. Med. Chem. Lett. 8, 2297-2302.
41. Krebs, S. & Rognan, D. (1998) From peptides to peptidomimetics: design of nonpeptide ligands for major histocompatibility proteins. Pharm. Acta Helv. 73, 173-181.
42. Henlin, J.M., Boutin, J.A., Kucharczyk, N., Desmet-Beaufort, C., Loynel, A., Bertrand, M., Genton, A., Tucker, G.C., Atassi, G. & Fauchere, J.L. (2001) From peptide libraries to optimized nonpeptide ligands in the search for S-famesyltransferase inhibitors. J. Pept. Res. 57, 85-96.
43. Kieber-Emmons, T., Murali, R. & Greene, M.I. (1997) Therapeutic peptides and peptidomimetics. Curr. Opin. Biotechnol. 8, 435-441.
44. Katz, B.A. (1997) Structural and mechanistic determinants of affinity and specificity of ligands discovered or engineered by phage display. Annu. Rev. Biophys. Biomol. Struct. 26, 27-45.
45. Oj, V.T. & Herzenberg, T. (1980) Immunoglobulin-producing hybrid cell lines. In Selected Methods in Cellular Immunology (Mishell, B.B. & Shiigi, S.M., eds), H.H. Freeman, New York.
46. Larson, R.S., Brown, D.C. & Sklar, L.A. (1997) Retinoic acid induces aggregation of the acute promyelocytic leukemia cell line NB-4 by utilization of LFA-1 and ICAM-2. Blood 90, 2747-2756.
47. Rothlein, R. & Springer, T.A. (1986) The requirement for lymphocyte function-associated antigen 1 in homotypic leukocyte adhesion stimulated by phorbol ester. J. Exp. Med. 163, 1132-1149.
48. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J. & Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293.
49. Farrar, T.C. & Becker, E.D. (1971) Pulse and Fourier Transform NMR: Introduction to Theory and Methods. Academic Press, New York.
50. Wuthrich, K., Billeter, M. & Braun, W. (1983) Pseudo-structures for the 20 common amino acids for use in studies of protein conformations by measurements of intramolecular proton-proton distance constraints with nuclear magnetic resonance. J. Mol. Biol. 169, 949-961.
51. Pardi, A., Billeter, M. & Wuthrich, K. (1984) Calibration of the angular dependence of the amide proton-C alpha proton coupling constants, 3JHN alpha, in a globular protein. Use of 3JHN alpha for identification of helical secondary structure. J. Mol. Biol. 180, 741-751.
52. Karplus, M. (1959) Contact electron-spin coupling of nuclear magnetic moments. J. Chem. Phy. 30, 11-15.
53. Havel, T.F. (1991) An evaluation of computational strategies for use in the determination of protein structure from distance constraints obtained by nuclear magnetic resonance. Prog. Biophys. Mol. Biol. 56, 43-78.
54. Havel, T.F. (1990) The sampling properties of some distance geometry algorithms applied to unconstrained polypeptide chains: a study of 1830 independently computed conformations. Biopolymers 29, 1565-1585.
55. Crippen, G.M. & Havel, T.F. (1978) Stable calculation of coordinates from distance information. Acta Cryst. A34, 282-284.
56. Crippen, G.M. & Havel, T.F. (1988) Distance Geometry and Molecular Conformation. Research Studies Press, UK.
57. Asakura, T., Taoka, K., Demura, M. & Williamson, M.P. (1995) The relationship between amide proton chemical-shifts and secondary structure in proteins. J. Biomol. NMR 6, 227-236.
58. Wuthrich, K. (1986) NMR of Proteins and Nucleic Acids. J. Wiley and Sons, New York.
59. Asensio, J.L., Martin-Pastor, M. & Jimenez-Barbero, J. (1995) The use of CVFF and CFF91 force fields in conformational analysis of carbohydrate molecules. Comparison with AMBER molecular mechanics and dynamics calculations for methyl alpha-lactoside. Int. J. Biol. Macromol. 17, 137-148.
60. Plaxco, K.W., Morton, C.J., Grimshaw, S.B., Jones, J.A., Pitkeathly, M., Campbell, I.D. & Dobson, C.M. (1997) The effects of guanidine hydrochloride on the 'random coil' conformations and NMR chemical shifts of the peptide series GGXGG. J. Biomol. NMR 10, 221-230.
61. Smith, L.J., Bolin, K.A., Schwalbe, H., MacArthur, M.W., Thornton, J.M. & Dobson, C.M. (1996) Analysis of main chain torsion angles in proteins: prediction of NMR coupling constants for native and random coil conformations. J. Mol. Biol. 255, 494-506.
62. Kessler, H. (1982) Peptide Conformations. 19. Conformation and biological-activity of cyclic-peptides. Angew Chem. Int. Ed. Engl. 21, 512-523.
63. Gursoy, R.N., Jois, D.S. & Siahaan, T.J. (1999) Structural recognition of an ICAM-1 peptide by its receptor on the surface of T cells: conformational studies of cyclo (1, 12)-Pen-Pro-Arg-Gly-Gly-Ser-Val-Leu-Val-Thr-Gly-Cys-OH. J. Pept. Res. 53, 422-431.
64. Ogru, E., Wilson, J.C., Heffernan, M., Jiang, W.J., Chalmers, D.K., Libinaki, R. & Ng, F. (2000) The conformational and biological analysis of a cyclic anti-obesity peptide from the C-terminal domain of human growth hormone. J. Pept. Res. 56, 388-397.
65. Hu, C.K., Agner, K.E., Orning, L., Sakariassen, K.S., Stephens, R.W., Llinas, M. & Fischer, P.M. (2001) Synthesis, biological activity, and solution structures of a cyclic dodecapeptide from the EGF-2 domain of blood coagulation factor VII. J. Pept. Res. 57, 462-472.
66. Karawajczyk, B., Wirkus-Romanowska, I., Wysocki, J., Roka, K., Mackiewicz, Z., Glosnicka, R. & Kupryszewski, G. (2001) Cyclic analogue of human heat shock protein fragment. Synthesis, conformational studies and evaluation of its immunogenicity. Polish. J. Chem. 75, 265-273.
67. Chen, C., Hsu, C.H., Su, N.Y., Lin, Y.C., Chiou, S.H. & Wu, S.H. (2001) Solution structure of a Kunitz-type chymotrypsin inhibitor isolated from the elapid snake Bungarus fasciatus. J. Biol. Chem. 276, 45079-45087.
68. Chou, K.C. (2000) Prediction of tight turns and their types in proteins. Anal. Biochem. 286, 1-16.
69. Leprince, J., Oulyadi, H., Vaudry, D., Masmoudi, O., Gandolfo, P., Patte, C., Costentin, J., Fauchere, J. L., Davoust, D., Vaudry, H. & Tonon, M.C. (2001) Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist. Eur. J. Biochem. 268, 6045-6057.
70. Tamamura, H., Sugioka, M., Odagaki, Y., Omagari, A., Kan, Y., Oishi, S., Nakashima, H., Yamamoto, N., Peiper, S.C., Hamanaka, N., Otaka, A. & Fujii, N. (2001) Conformational study of a highly specific CXCR4 inhibitor, T140, disclosing the close proximity of its intrinsic pharmacophores associated with strong anti-HIV activity. Bioorg. Med. Chem. Lett. 11, 359-362.
71. Brauer, A.B., Kelly, G., McBride, J.D., Cooke, R.M., Matthews, S.J. & Leatherbarrow, R.J. (2001) The Bowman-Birk inhibitor reactive site loop sequence represents an independent structural beta-hairpin motif. J. Mol. Biol. 306, 799-807.
72. Bogusky, M.J., Culberson, J.C., Pitzenberger, S.M., Garsky, V.M., Wallace, A., Pessi, A. & Koblan, K.S. (1999) Conformation of a novel tetrapeptide inhibitor NH2-D-Trp-D-Met-Phe(pCl)-Gla-NH2 bound to farnesyl-protein transferase. J. Pept. Res. 54, 66-73.
73. Xu, C.R., Yusuf-Makagiansar, H., Hu, Y., Jois, S.D. & Siahaan, T.J. (2002) Structural and ICAM-1-docking properties of a cyclic peptide from the I-domain of LFA-1: an inhibitor of ICAM-1/LFA-1-mediated T-cell adhesion. J. Biomol. Struct. Dyn. 19, 789-799.
74. Kanyalkar, M., Srivastava, S. & Coutinho, E. (2001) Conformation of N-terminal HIV-1 Tat (fragment 1-9) peptide by NMR and MD simulations. J. Pept. Sci. 7, 579-587.
75. Sahu, A., Soulika, A.M., Morikis, D., Spruce, L., Moore, W.T. & Lambris, J.D (2000). Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J. Immunol. 165, 2491-2499.
76. Bogdanowich-Knipp, S.J., Jois, S.D. & Siahaan, T.J. (1999) Effect of conformation on the conversion of cyclo-(1,7) -Gly-Arg-Gly-Asp-Ser-Pro-Asp-Gly-OH to its cyclic imide degradation product. J. Pept. Res. 54, 43-53.
77. Fry, D.C. & Emerson, S.D. (2000) Applications of biomolecular NMR to drug discovery. Drug Des. Discov. 17, 13-33.
78. Roberts, G.C. (2000) Applications of NMR in drug discovery. Drug Discov. Today 5, 230-240.
79. Fairbrother, W.J., Christinger, H.W., Cochran, A.G., Fuh, G., Keenan, C.J., Quan, C., Shriver, S.K., Tom, J.Y., Wells, J.A. & Cunningham, B.C. (1998) Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site. Biochemistry 37, 17754-17764.
80. Wiesmann, C., Christinger, H.W., Cochran, A.G., Cunningham, B.C., Fairbrother, W.J., Keenan, C.J., Meng, G. & DeVos, A.M. (1998) Crystal structure of the complex between VEGF and a receptor-blocking peptide. Biochemistry 37, 17765-17772.